DNA replication inhibitors (Biota/La Trobe)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug NameDNA replication inhibitors (Biota/La Trobe)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA topoisomerase inhibitors
TargetsDNA topoisomerase
Therapy Area/IndicationsLung NeoplasmsStomach NeoplasmsColonic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLa Trobe University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiota Holdings LtdLa Trobe University
Active IndicationsN/A
Inactive IndicationsLung NeoplasmsStomach NeoplasmsColonic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A